Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00385970
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (4)

leucovorin (1 trial)

polysaccharide-k (1 trial)

tegafur (1 trial)

uracil (1 trial)

Drugs in Other Trials (2)

aprepitant (Emend) (1 trial)

immune globulin (human) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6